Obesity Clinical Trial
Official title:
Association Between Pulses/Legumes and Cardiometabolic Disease Outcomes: An Umbrella Review and Updated Systematic Review and Meta-analysis of Prospective Cohort Studies
The European Association for the Study of Diabetes (EASD) guidelines have not made any specific recommendations regarding dietary pulses. To update the recommendations, the Diabetes and Nutrition Study Group (DNSG) of the EASD commissioned an umbrella review and updated systematic review and meta-analysis using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to summarize the available evidence from prospective cohort studies of the association between dietary pulses/legumes and cardiometabolic disease outcomes (incident cardiovascular diseases, diabetes, hypertension and overweight/obesity).
Background: Dietary pulses, the edible dried seeds of legumes, are high in fiber, plant
protein, and various micronutrients and low in fat and glycemic index (GI), have shown a wide
range of health benefits for the prevention and management of type 2 diabetes and
cardiovascular disease. However, dietary pulses are not well recognized for these advantages.
Recommendations for dietary pulse intake vary across chronic disease guidelines. In specific,
the European Association for the Study of Diabetes (EASD) guidelines for nutrition therapy
have not made any specific recommendations regarding dietary pulses. The present umbrella
review and updated systematic review and meta-analysis using the Grading of Recommendations
Assessment, Development, and Evaluation (GRADE) approach was thus commissioned by the
Diabetes and Nutrition Study Group (DNSG) of the EASD to summarize the available evidence
from prospective cohort studies of the association between dietary pulses/legumes and
cardiometabolic disease outcomes (incident cardiovascular diseases, diabetes, hypertension
and overweight/obesity).
Need for proposed research: High quality systematic reviews and meta-analyses represent the
highest level of evidence to support dietary guidelines and public health policy development.
As dietary guidelines and public health policy have shifted toward food and dietary-pattern
based recommendations, there is a need for a systematic review and meta-analysis assessing
the pooled association between dietary pulses/legumes and cardiometabolic disease outcomes.
Objective: The investigators will conduct an umbrella review and updated systematic review
and meta-analysis to summarize the association between dietary pulses/legumes and
cardiometabolic disease outcomes in prospective cohort studies.
Design: The umbrella review will consist of a literature search of the most recent and/or
comprehensive systematic reviews and meta-analyses published in this area. The included
systematic reviews and meta-analyses will be updated conducting a systematic search for
prospective cohort studies published after the census dates of the included systematic
reviews and meta-analyses. The planning and conduct of the updated systematic review and
meta-analysis will follow the Cochrane handbook for systematic reviews of interventions. The
reporting will follow the Meta-analysis Of Observational Studies in Epidemiology (MOOSE)
guidelines.
Data sources:
The umbrella review will consist of searching PubMed databases using appropriate search terms
to identify the most recent and/or comprehensive systematic reviews and meta-analyses
published in this area. The updated systematic review and meta-analysis will consist of
searching MEDLINE, EMBASE, and The Cochrane Central Register of Controlled Trials after the
census dates of the included systematic reviews and meta-analyses from the umbrella review
using appropriate search terms supplemented by manual searches of references of included
studies. Authors will be contacted for applicable missing data.
Study selection:
The umbrella review will include the most recent and/or comprehensive systematic reviews and
meta-analyses of prospective cohort studies assessing the association between pulse/legume
intake and cardiometabolic diseases outcomes (cardiovascular diseases, diabetes,
hypertension, overweight/obesity). The updated systematic review and meta-analysis will
include prospective cohort studies ≥1 year assessing the association between pulse/legume
intake and cardiometabolic diseases outcomes (cardiovascular diseases, diabetes,
hypertension, overweight/obesity) published since the last census dates of the included
systematic reviews and meta-analyses from the umbrella review.
Data extraction: Data from prospective cohort studies in the most recent and/or comprehensive
systematic reviews and meta-analyses will be included in the updated systematic review and
meta-analysis. For newly identified prospective cohort studies, two or more investigators
will independently extract relevant data and assess risk of bias using the Newcastle-Ottawa
Scale (NOS) for observational studies. Risk ratios, odds ratios and hazard ratios for
clinical outcomes will be extracted or derived from clinical event data across quantiles of
exposure. All disagreements will be resolved by consensus.
Outcomes: The primary outcome of the systematic review and meta-analysis will be incident
cardiovascular disease. Secondary outcomes will include incident coronary heart disease,
stroke, diabetes, hypertension and overweight/obesity.
Data synthesis: The natural log-transformed relative risks of outcomes comparing the exposure
to the reference group from each cohort will be pooled using the generic inverse variance
method with random effects models and expressed as risk ratios (RR) with 95% confidence
intervals (CIs). Heterogeneity will be assessed by Cochran Q statistic and quantified by I2.
The significance level will be set at p<0.10 and an I2≥ 50% will be considered evidence of
substantial heterogeneity. To explore sources of heterogeneity, the investigators will
conduct sensitivity analyses, in which each study is systematically removed with
recalculation of the summary estimates. If there are ≥10 studies, then the investigators will
also explore sources of heterogeneity by a priori subgroup analyses (cohorts, sex, health
status, follow-up [<10-years, ≥10-years], dose, level of adjustment of models, quality of the
studies (NOS), and validation of the dietary assessment instruments). Meta-regression
analyses will be used to assess the significance of categorical and continuous subgroups
analyses. If there are ≥10 studies available, publication bias will be assessed by the visual
inspection of funnel plots and formal testing using Begg's and Egger's tests. If publication
bias is suspected, then the investigators will attempt to adjust for funnel plot asymmetry by
imputing the missing study data using the Duval and Tweedie trim and fill method.
Evidence Assessment: The certainty of the evidence for each outcome will be assessed using
the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.
Knowledge translation plan: The results will be disseminated through interactive
presentations at local, national, and international scientific meetings and publication in
high impact factor journals. Target audiences will include the public health and scientific
communities with interest in nutrition, diabetes, obesity, and cardiovascular disease.
Feedback will be incorporated and used to improve the public health message and key areas for
future research will be defined. Applicant/Co-applicant Decision Makers will network among
opinion leaders to increase awareness and participate directly as committee members in the
development of future guidelines.
Significance: The proposed project will aid in knowledge translation related to the role of
dietary pulses in cardiometabolic disease risk, strengthening the evidence-base for
guidelines and improving health outcomes by educating healthcare providers and patients,
stimulating industry innovation, and guiding future research design.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |